Women's Health
Is Low Mood Normal in Menopause?
Up to 40% of women experience clinically significant depressive symptoms during the menopause transition — yet most are never told why, or that specific hormonal mechanisms are driving it. Low mood in menopause is common, but it is not simply 'part of getting older,' and the distinction matters enormously for how you address it.

Is Low Mood Normal in Menopause?
Yes, low mood is common in menopause — but 'normal' doesn't mean unavoidable. Fluctuating and falling estrogen disrupts serotonin, GABA, and cortisol signaling in ways that genuinely alter brain chemistry. The main caveat: severity varies hugely depending on your transition type, prior mood history, and testosterone levels. Women with surgical menopause or a history of PMS are at significantly higher risk than the average perimenopausal woman.
---
Why Hormonal Change Affects Your Brain
Estrogen is not just a reproductive hormone. It acts as a neuromodulator throughout the central nervous system, upregulating serotonin receptor sensitivity, promoting GABA activity, and supporting the production of brain-derived neurotrophic factor (BDNF) — a protein critical to mood resilience and neuroplasticity (Lokuge et al., Journal of Clinical Psychiatry 2011; PMID: 20492840). When estrogen levels fall or fluctuate rapidly during perimenopause, these systems destabilize together.
Progesterone metabolites, specifically allopregnanolone, also bind GABA-A receptors to produce calming, anxiolytic effects. As progesterone drops, women often report increased anxiety, irritability, and sleep disruption — all of which compound low mood. Simultaneously, the hypothalamic-pituitary-adrenal (HPA) axis becomes more reactive, raising cortisol and making stress harder to buffer (Schiller et al., Psychoneuroendocrinology 2014; PMID: 24845176).
This is not a character flaw or a failure to cope. It is a predictable neurochemical cascade triggered by endocrine change.
---
Is Low Mood Normal in Early Menopause?
Perimenopause — the years before your final period — is often the highest-risk window for mood disruption, not postmenopause. A landmark longitudinal study from the Penn Ovarian Aging Study followed women for 14 years and found that the risk of a high depressive symptom score was 2.5 times greater during the menopausal transition than in premenopause, even after controlling for prior history of depression (Freeman et al., Archives of General Psychiatry 2006; PMID: 16894061).
The volatility of early menopause is actually the problem. Estrogen does not simply fall in a straight line — it lurches up and down for years, and it is these fluctuations, not just the absolute low level, that appear to dysregulate mood circuits. This explains why many women feel worse in perimenopause than in postmenopause, when estrogen stabilizes at a consistently lower level.
Risk factors that elevate your likelihood of significant low mood in early menopause include:
- History of premenstrual dysphoric disorder (PMDD) or postnatal depression
- Poor sleep quality or sleep apnea
- High perceived stress or recent life stressors
- Low social support
- Vitamin D insufficiency (levels below 30 ng/mL have been independently associated with depressive symptoms)
- Elevated high-sensitivity CRP — chronic low-grade inflammation is now recognized as a contributor to mood disorder biology
If you have elevated inflammation markers, it is worth reading what a normal CRP level means on your lab report before assuming your low mood is purely hormonal.
---
Is Low Mood Normal with Low Testosterone?
Testosterone is frequently overlooked in discussions of women's menopause symptoms, but total and free testosterone decline from the mid-30s onward and can fall sharply after ovarian function declines. Low testosterone in women is associated with reduced motivation, flattened affect, cognitive fog, and loss of libido — a cluster that is often mistaken for depression or burnout.
A 2019 systematic review and meta-analysis in The Lancet Diabetes & Endocrinology covering 8,480 participants found that testosterone therapy in women significantly improved sexual function, but also reported meaningful improvements in general wellbeing and mood outcomes in several included trials (Davis et al., The Lancet Diabetes & Endocrinology 2019; PMID: 31353194).
Clinically, women's testosterone is often not tested during routine menopause workups. If your low mood comes with reduced drive, difficulty concentrating, and physical fatigue rather than tearfulness and hopelessness, request a free testosterone alongside SHBG — free testosterone is the biologically active fraction that matters most. You can also explore how low testosterone interacts with other metabolic signals, including what a suboptimal HbA1c level signals about energy and mood stability, in our guide to what is a normal HbA1c level.
---
Is Low Mood Normal in Surgical Menopause?
Surgical menopause — triggered by bilateral oophorectomy (removal of both ovaries) — is categorically different from natural menopause in its psychological impact. Natural menopause unfolds over years; surgical menopause causes estrogen, progesterone, and testosterone to plummet within 24 to 48 hours. The brain has no time to adapt.
Studies consistently show that women who undergo surgical menopause before natural age have significantly higher rates of depression and anxiety than age-matched women in natural menopause. A large population-based cohort study found that oophorectomy before age 46 was associated with a 54% increased risk of depressive or anxiety disorders over the subsequent 30-year follow-up (Rocca et al., Menopause 2008; PMID: 18797427).
If you had a surgical menopause and are experiencing mood symptoms, the urgency for hormone evaluation is higher than in natural menopause — estrogen deficiency is essentially guaranteed, and the window for intervention appears to matter for long-term brain health. This is not a situation to wait and see.
Important considerations specific to surgical menopause:
- Request a full hormonal panel including estradiol, FSH, total and free testosterone, and SHBG within weeks of surgery.
- Discuss hormone therapy (HT) timing with a menopause specialist — early initiation within the 'window of opportunity' is associated with better mood and cognitive outcomes.
- Prioritize sleep intervention — the abrupt loss of allopregnanolone destroys sleep architecture rapidly, which independently worsens mood.
- Consider targeted nutritional support for HPA axis resilience while HT decisions are being made.
---
Is Low Mood Normal When Coming Off the Pill?
This is a distinct but related scenario. Combined oral contraceptives suppress the HPG (hypothalamic-pituitary-gonadal) axis, delivering synthetic hormones and suppressing your own estrogen and testosterone production. When you stop the pill, your body must restart its own hormonal signaling — a process that can take months and often does not restore to baseline immediately.
Several studies have identified persistent low mood, anxiety, and reduced libido in the months after pill cessation, which some researchers attribute to prolonged SHBG elevation. The pill dramatically raises SHBG (the protein that binds testosterone), and SHBG can remain elevated for months after stopping, leaving free testosterone suppressed even when total testosterone looks normal (Panzer et al., Journal of Sexual Medicine 2006; PMID: 16681470).
For women in perimenopause who have been on the pill, coming off can unmask menopausal symptoms that were previously masked by the synthetic hormones — including low mood, hot flashes, and disrupted sleep. This can create diagnostic confusion: is this a pill withdrawal effect, perimenopause, or both? Often, it is both.
In this transition window, mood-supporting nutritional strategies can provide meaningful bridging support while the hormonal picture clarifies.
---
Biomarkers Worth Investigating Before Supplementing
Low mood in menopause is multifactorial. Before adding supplements, it is worth checking the following — ideally as a panel rather than in isolation:
| Biomarker | Optimal Range | Why It Matters for Mood |
|---|---|---|
| Estradiol | Context-dependent by phase/stage | Central neuromodulator |
| Free Testosterone | >1.0 pg/mL (varies by lab) | Motivation, affect, drive |
| SHBG | 40–120 nmol/L | Modulates free testosterone |
| Vitamin D (25-OH) | 40–60 ng/mL | Serotonin synthesis co-factor |
| hs-CRP | <1.0 mg/L | Inflammatory mood driver |
| Fasting Insulin | <6 µIU/mL | Metabolic stability |
| TSH + Free T3 | TSH 1.0–2.5 mIU/L | Thyroid directly affects energy and mood |
Thyroid dysfunction — particularly subclinical hypothyroidism — closely mimics menopausal mood symptoms and is more common in perimenopausal women. If your fasting insulin is creeping upward alongside your mood changes, that metabolic signal deserves attention too; our evidence-based guide on fasting insulin and what it means when everything else looks normal explains why.
---
What This Means for Your Formula
Ones is an AI health platform that reads your blood work, wearable data, and health history to build a personalized daily supplement formula — which is particularly relevant for menopausal mood symptoms, where the combination of factors matters more than any single deficiency.
For women navigating menopausal low mood, three ingredients in the Ones catalog are most directly relevant:
Ashwagandha (KSM-66, 600 mg): One of the most rigorously studied adaptogens for HPA axis regulation. A double-blind RCT in 60 adults found KSM-66 at 600 mg/day significantly reduced serum cortisol, perceived stress scores, and anxiety over 60 days (Chandrasekhar et al., Indian Journal of Psychological Medicine 2012; PMID: 23439798). In perimenopause — where cortisol reactivity is heightened and the stress-mood spiral is real — this is a mechanistically sound inclusion.
Vitamin D3 + K2 (MK-7): Vitamin D receptors are expressed throughout brain regions that regulate mood, and low 25-OH vitamin D is independently associated with depressive symptom severity. The K2 pairing ensures calcium is directed to bone rather than vasculature. If your vitamin D is below 40 ng/mL and you're experiencing low mood, this is foundational — not optional. For a deeper look at how vitamin D deficiency cascades into energy and hormonal symptoms, see our article on vitamin D deficiency symptoms and testing.
Ones Adrenal Support Blend: The Adrenal Support System Blend is formulated for women (and men) whose HPA axis is dysregulated — which describes a significant proportion of perimenopausal women. Chronic HPA activation depletes DHEA, disrupts the cortisol awakening response, and worsens sleep architecture. Addressing adrenal resilience alongside hormonal changes is a clinically coherent strategy that many standard menopause protocols overlook.
Ones does not replace hormone therapy, and neither does any supplement. But for women who are between appointments, deciding whether to start HT, or looking to optimize alongside it, a data-driven personalized formula can address the specific nutritional gaps that amplify menopausal mood symptoms.
---
Key Takeaways
- Low mood in menopause is common and has clear neurochemical causes — falling estrogen destabilizes serotonin, GABA, and cortisol signaling simultaneously.
- Perimenopause, not postmenopause, is typically the highest-risk period because estrogen fluctuations — not just the low level — are the primary driver.
- Surgical menopause carries the highest mood risk of all transition types and warrants prompt hormonal evaluation and specialist input.
- Low testosterone is an underrecognized contributor; request free testosterone and SHBG alongside estradiol if motivation, drive, and cognitive function are affected.
- Coming off the pill can unmask menopausal mood symptoms and suppress free testosterone for months via SHBG elevation.
- Biomarkers including vitamin D, hs-CRP, fasting insulin, and TSH should be checked before supplementing — Ones uses this data to build a formula calibrated to your specific picture, not a generic menopause stack.